J&J strikes deal with US government to cut drug prices, gain tariff exemptions
CNBC••general
Key Points:
- Johnson & Johnson has reached an agreement with the Trump administration to reduce drug prices for Americans in exchange for exemptions from U.S. tariffs, aligning with similar deals made by nine other major pharmaceutical companies.
- The agreement includes participation in the TrumpRx.gov website, offering discounted drug prices to consumers, and providing Medicaid access at prices comparable to those in other developed countries.
- Specific terms of the deal, including exact drug price reductions and covered medicines, were not disclosed by Johnson & Johnson.
- This move is part of broader efforts to address the significantly higher prescription drug costs in the U.S., which often exceed prices in other wealthy nations by nearly three times.
- Johnson & Johnson also announced plans to build two new manufacturing facilities in North
